Wednesday, July 6, 2022
Home Industry Biotech

Biotech

Over the next five years, Samsung plans to invest $360 billion on microchips and biotech

As South Korea's conglomerates cope with mounting economic and supply shocks, Samsung aims to increase expenditure by more than 30% to 450 trillion won...

The Environment and Artificial Intelligence

The United Nations issued our most dire climate warning to date in 2021: a code red for humanity. The threat of intensified climate disasters,...

Big Pharma is resisting the temptation to go on a biotech M&A rush until prices go much lower

While falling valuations are pushing biotechs to lay off employees and pare down their pipelines, Big Pharma doesn't believe the bargains on offer are...

The SEC’s environment rule has energized the venture capital industry

Greg Smithies helped Elon Musk market flamethrowers, but he's equally enthusiastic about climate technology. Smithies is a partner at Fifth Wall, a VC firm...

Coquitlam is seeking environmental technologies from IT companies

Coquitlam has set this objective as part of its new environmental sustainability strategy (ESP), which also includes a 45 percent reduction in gas emissions...

Thales introduces a payment card with a fingerprint scanner built-in.

Do you want to make a payment with a poke? A Secure Innovation in Your Pocket: Thales Biometric Payment Card Thales has introduced the "world's...

AI firm DeepMind puts database of the building blocks of life online

Last year the artificial intelligence group DeepMind cracked a mystery that has flummoxed scientists for decades: stripping bare the structure of proteins, the building...

Eva: The new AI Champion of Greece in Testing Covid-19

This spring Greece, a country for which tourism is a key part of its economy, faced a dilemma. Whether to open its gates to...

MEI Pharma to Host Investor and Analyst Video Webcast

MEI Pharma, Inc., a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that it will host an investor and analyst...

Continuation of Partial Clinical Hold of Gemcabene From NeuroBo

NeuroBo Pharmaceuticals, Inc. a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced that...

Must Read